Results from two early-stage trials offer new hope for a cancer that kills around one in eight patients within five years.

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

As one of the world’s leading experts in pancreatic cancer, Prof Andrew Biankin is all too familiar with the aura of dread ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

A high–fat, low–carbohydrate diet could help improve how the pancreas functions in people with type 2 diabetes, according to ...

New experimental medications seem to extend survival with the hard-to-treat cancer.

A breakthrough in our understanding of mRNA delivery systems in the body may allow for more direct treatments for pancreas-related diseases, including cancer and diabetes. A new UNLV study by a team ...

The top signs of pancreas problems are easy to mistake for other conditions. Here, experts share what you need to watch for ...

Pancreatic cancer is a very challenging disease. It’s tough to catch early, spreads rapidly, and doesn’t respond easily to treatment. This year, pancreatic cancer is expected to be the 12th most ...

Pancreatic cancer remains one of the most challenging cancers to detect early, contributing to its reputation as a silent disease with poor survival rates. The pancreas—a leaf-shaped organ tucked ...

Type 1 diabetes (T1D) impacts nearly two million Americans, and by the time most people learn they have it, most of the body's insulin-producing cells are destroyed. Now, pinpointing a hidden group of ...

The most common pathology affecting the pancreas is excess intra-pancreatic fat deposition (IPFD), often called fatty pancreas disease (FPD) — a disorder experienced by roughly one fifth of the ...